BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 22173166)

  • 1. Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: results from ANRS CO13 HEPAVIH.
    Salmon D; Bani-Sadr F; Loko MA; Stitou H; Gervais A; Durant J; Rosenthal E; Quertainmont Y; Barange K; Vittecoq D; Shoai-Tehrani M; Alvarez M; Winnock M; Trinchet JC; Dabis F; Sogni P
    J Hepatol; 2012 Apr; 56(4):862-8. PubMed ID: 22173166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance, serum leptin, and adiponectin levels and outcomes of viral hepatitis C cirrhosis.
    Nkontchou G; Bastard JP; Ziol M; Aout M; Cosson E; Ganne-Carrie N; Grando-Lemaire V; Roulot D; Capeau J; Trinchet JC; Vicaut E; Beaugrand M
    J Hepatol; 2010 Nov; 53(5):827-33. PubMed ID: 20728234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001.
    Giordano TP; Kramer JR; Souchek J; Richardson P; El-Serag HB
    Arch Intern Med; 2004 Nov; 164(21):2349-54. PubMed ID: 15557414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
    Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
    Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
    Fattovich G; Pantalena M; Zagni I; Realdi G; Schalm SW; Christensen E;
    Am J Gastroenterol; 2002 Nov; 97(11):2886-95. PubMed ID: 12425564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing incidence of hepatocellular carcinoma in HIV-infected patients in Spain.
    Merchante N; Merino E; López-Aldeguer J; Jover F; Delgado-Fernández M; Galindo MJ; Ortega E; Rivero A; Mínguez C; Romero-Palacios A; Padilla S; Márquez-Solero M; Amador C; Ríos-Villegas MJ; Téllez F; Portilla J; Pineda JA
    Clin Infect Dis; 2013 Jan; 56(1):143-50. PubMed ID: 22955438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.
    Ascha MS; Hanouneh IA; Lopez R; Tamimi TA; Feldstein AF; Zein NN
    Hepatology; 2010 Jun; 51(6):1972-8. PubMed ID: 20209604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C.
    Kramer JR; Giordano TP; Souchek J; Richardson P; Hwang LY; El-Serag HB
    Am J Gastroenterol; 2005 Jan; 100(1):56-63. PubMed ID: 15654781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
    Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
    Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of previous hepatitis B virus infection and heavy smoking in hepatitis C virus-related hepatocellular carcinoma.
    Chiba T; Matsuzaki Y; Abei M; Shoda J; Tanaka N; Osuga T; Aikawa T
    Am J Gastroenterol; 1996 Jun; 91(6):1195-203. PubMed ID: 8651170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C.
    García-Samaniego J; Rodríguez M; Berenguer J; Rodríguez-Rosado R; Carbó J; Asensi V; Soriano V
    Am J Gastroenterol; 2001 Jan; 96(1):179-83. PubMed ID: 11197250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia as a surrogate for cirrhosis and a marker for the identification of patients at high-risk for hepatocellular carcinoma.
    Lu SN; Wang JH; Liu SL; Hung CH; Chen CH; Tung HD; Chen TM; Huang WS; Lee CM; Chen CC; Changchien CS
    Cancer; 2006 Nov; 107(9):2212-22. PubMed ID: 17019738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
    Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
    Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008.
    Bruyand M; Dabis F; Vandenhende MA; Lazaro E; Neau D; Leleux O; Geffard S; Morlat P; Chêne G; Bonnet F
    J Hepatol; 2011 Nov; 55(5):1058-62. PubMed ID: 21354449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ANRS-fibrovic and homavic: role of non invasive markers of liver fibrosis and insulin resistance during antiviral treatment in HIV-HCV co-infected patients from ANRS HC 02 RIVABIC trial].
    Halfon P; Pénaranda G; Cacoub P
    Gastroenterol Clin Biol; 2009 Mar; 33 Suppl 2():S113-7. PubMed ID: 19375039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C.
    Yamauchi M; Nakahara M; Maezawa Y; Satoh S; Nishikawa F; Ohata M; Mizuhara Y; Hirakawa J; Nakajima H; Fujisawa K
    Am J Gastroenterol; 1993 Jan; 88(1):39-43. PubMed ID: 7678368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study.
    Bruno S; Silini E; Crosignani A; Borzio F; Leandro G; Bono F; Asti M; Rossi S; Larghi A; Cerino A; Podda M; Mondelli MU
    Hepatology; 1997 Mar; 25(3):754-8. PubMed ID: 9049231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study.
    Salmon-Ceron D; Rosenthal E; Lewden C; Bouteloup V; May T; Burty C; Bonnet F; Costagliola D; Jougla E; Semaille C; Morlat P; Cacoub P; Chêne G;
    J Hepatol; 2009 Apr; 50(4):736-45. PubMed ID: 19231018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.